Vacancy for Chair, British Cardiovascular Society Digital and IT Committee Could you be the next Chair of the Digital and IT Committee at a critical…
View More Calling trainee or ordinary members of the BCS…
Author: CardioNewsUK
BCS congratulates Professor Mark Monaghan on his MBE
The BCS is delighted that Professor Mark Monaghan, Director of Invasive Cardiology and a consultant clinical scientist at King’s College London, is today receiving an…
View More BCS congratulates Professor Mark Monaghan on his MBE
Key points from the most recent European consensus document on antithrombotic treatment strategies
By Dr. Aswin BabuEdited by Dr. Ahmed El-Medany The evidence and landscape around anti-platelet and anticoagulation strategies for established coronary disease continues to evolve and…
View More Key points from the most recent European consensus document on antithrombotic treatment strategies
New EHRA expert consensus on the management of arrhythmia in frailty syndrome
By Dr. Timothy SwinnEdited by Dr. Ahmed El-Medany The European Heart Rhythm Association has recently released the first consensus statement on management of arrhythmias in…
View More New EHRA expert consensus on the management of arrhythmia in frailty syndrome
Predicting left ventricular ejection fraction improvement after atrial fibrillation ablation
By Dr Megha AgarwalEdited by Dr Saadia Aslam Atrial fibrillation (AF) and heart failure (HF) often co-exist and in combination are associated with increased mortality.…
View More Predicting left ventricular ejection fraction improvement after atrial fibrillation ablation
ChatGPT versus the EECC – another win for artificial intelligence?
By Dr. Ahmed El-Medany A recent study published in the European Heart Journal: Digital Health, by Skalidis et al, has demonstrated the potential of artificial…
View More ChatGPT versus the EECC – another win for artificial intelligence?
Transient very low LDL cholesterol levels reduce risk of major cardiovascular events following ACS
By Dr. Florence MouyEdited by Dr Saadia Aslam The ODYSSEY Outcomes trial in 2018 showed that PCSK9i (proprotein convertase subtilisin/kexin type 9 inhibitor) alirocumab reduced…
View More Transient very low LDL cholesterol levels reduce risk of major cardiovascular events following ACS
The use of Artificial Intelligence in analysing statin-related sentiments on social media – the perception is mostly neutral, or negative…
By Dr. Ahmed El-Medany Despite their efficacy and safety profile, statins are underused, even in patients with the highest cardiovascular disease risk. Social media platforms…
View More The use of Artificial Intelligence in analysing statin-related sentiments on social media – the perception is mostly neutral, or negative…
Are high-power electric vehicle chargers safe in patients with pacemakers and defibrillators?
By Dr. Ahmed El-Medany A new study published in Europace by Lennerz et al. aimed to evaluate the potential electromagnetic interference (EMI) that high-power charging…
View More Are high-power electric vehicle chargers safe in patients with pacemakers and defibrillators?
The AFLETES study: AF burden and risk in veteran athletes
By Dr Jonathan ShurlockEdited by Dr Ahmed El-Medany It is well understood that endurance athletes are at increased risk of atrial fibrillation (AF) when compared…
View More The AFLETES study: AF burden and risk in veteran athletes